Skip to main content
. 2016 Jul 22;16:41. doi: 10.1186/s12871-016-0210-5

Table 1.

Patients’ characteristics and clinical data

Placebo Ondansetron Ramosetron
(n = 31) (n = 26) (n = 32)
Age, years 34.10 ± 15.14 35.69 ± 17.13 34.13 ± 13.66
Weight, kg 61.38 ± 9.50 65.32 ± 10.63 59.64 ± 10.39
Height, cm 163.82 ± 10.79 167.70 ± 9.63 165.49 ± 10.33
Sex, M/F 14/17 14/12 13/19
PONV Hx., n (%) 2 (6.45) 2 (7.69) 2 (6.25)
Motion sickness, n (%) 12 (38.71) 10 (38.46) 13 (40.63)
Non-smoker, n (%) 20 (64.52) 17 (65.38) 21 (65.63)
Duration of surgery, min 23.90 ± 3.82 24.32 ± 3.72 24.05 ± 2.36
Duration of anesthesia, min 35.24 ± 7.92 35.95 ± 4.26 36.64 ± 4.97

Data are means ± SD or numbers. F female, M male